Pier Capital, LLC CRNX — Crinetics Pharmaceuticals Inc

Ownership history in Pier Capital, LLC  ·  8 quarters on record

AI Ownership Summary

Pier Capital, LLC reported Crinetics Pharmaceuticals Inc (CRNX) in 8 quarterly 13F filings from 2023 Q4 through 2025 Q3. Peak portfolio weight reached 0.82% in 2024 Q4. The latest visible filing shows CRNX at 0.49% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRNX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Pier Capital, LLC's position in Crinetics Pharmaceuticals Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

CRNX was reported at 0.49% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.82% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRNX stock page Pier Capital, LLC fund profile Pier Capital, LLC full holdings
How Pier Capital, LLC held CRNX — position size vs. price
% of Fund (quarterly)    CRNX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 REDUCED 47.4% +14.1% ❌ 75,000 -67,611 -47.4% 0.49% $3.1M 2025-11-13 $41.43
2025 Q2 ADDED — — — 142,611 +29,199 +25.7% 0.63% $4.1M 2025-08-05 $29.24
2025 Q1 ADDED — — — 113,412 +1,413 +1.3% 0.64% $3.8M 2025-05-13 $30.95
2024 Q4 ADDED — — — 111,999 +3,638 +3.4% 0.82% $5.7M 2025-02-11 $34.93
2024 Q3 REDUCED — — — 108,361 -184 -0.2% 0.78% $5.5M 2024-11-15 $54.72
2024 Q2 REDUCED 6.9% +14.1% ❌ 108,545 -8,025 -6.9% 0.72% $4.9M 2024-08-07 $48.30
2024 Q1 REDUCED — — — 116,570 -33 -0.0% 0.75% $5.5M 2024-05-03 $47.20
2023 Q4 INITIATED — — — 116,603 — — 0.59% $4.1M 2024-02-15 $36.92

🏢 Other funds also holding CRNX

As of 2026 Q1 — sorted by position size

MOODY ALDRICH PARTNERS LLC 3Y 7Y 1.2% BRAUN STACEY ASSOCIATES INC 3Y 7Y 0.39% Lewis Asset Management, LLC 0.39% PSP Research LLC 0.28% SANDERS MORRIS HARRIS LLC 3Y 7Y 0.12% Pictet Asset Management Holding SA 0.07% Bayforest Capital Ltd 0.04% PROFUND ADVISORS LLC 3Y 7Y 0.01% OPPENHEIMER ASSET MANAGEMENT INC. 3Y 7Y 0.01% PARK AVENUE SECURITIES LLC 3Y 7Y 0.0%

FAQ About Pier Capital, LLC and CRNX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Pier Capital, LLC reported owning CRNX?

Pier Capital, LLC reported CRNX across 8 quarterly 13F filings, from 2023 Q4 through 2025 Q3.

What was the largest reported CRNX position in Pier Capital, LLC's portfolio?

The largest reported portfolio weight for CRNX was 0.82% in 2024 Q4.

What is the latest reported CRNX position on this page?

The most recent filing on this page is 2025 Q3, when Pier Capital, LLC reported 75,000 shares, equal to 0.49% of portfolio, with an estimated market value of $3.1M.

What does the chart on this CRNX ownership page compare?

The chart compares Pier Capital, LLC's quarterly CRNX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Pier Capital, LLC time their CRNX position?

Based on 13F filing dates vs. subsequent CRNX price moves, Pier Capital, LLC correctly timed 3 out of 7 reported position changes (43%). The annualised alpha on CRNX relative to SPY over the holding period was -0.4%.

← Back to Pier Capital, LLC Holdings